we are hiring!

Dr. Timurs Maculins

Timurs pursued his interests in fundamental research by joining the laboratory of Karim Labib at the Manchester Cancer Research Centre in the United Kingdom after receiving a doctoral studentship from Cancer Research UK. Using the budding yeast as a model organism in his doctoral work, Timurs studied a role of a novel enzyme, known as SCFDia2 ubiquitin ligase, during DNA replication in the S phase of the cell cycle. Timurs continued his career as a postdoctoral scientist in the pharmaceutical industry in a collaborative project between the AstraZeneca High-Throughput Screening Centre and the academic laboratory headed by Ronald Hay. In late 2015 Timurs joined a collaborative project between the group of Ivan Dikic and Fraunhofer IME. Timurs has received the Human Frontier Science Program postdoctoral fellowship to study the role of ubiquitin ligase-like effectors during infection by lethal bacterial pathogens. He finished his work and moved on in 2018.